Title:
TREATMENT OF POST-TRAUMATIC SYNDROME DISORDER
Document Type and Number:
WIPO Patent Application WO/2019/113668
Kind Code:
A2
Abstract:
This invention is related to 3-(2-(4-(2-methoxyphenyl)piperazine-1-yl) ethyl) quinazoline-4(3H)-one, pharmaceutically acceptable salts, enantiomers, diasteroisomers, stereoisomers, crystals, hydrates, solvates, prodrugs, and metabolites thereof for the treatment of Post-Traumatic Syndrome Disorder (PTSD), and pharmaceutical compositions containing the compounds for the treatment of Post-Traumatic Syndrome Disorder (PTSD).
Inventors:
MASCARELLO ALESSANDRA (BR)
GUIMARÃES CRISTIANO RUCH WERNECK (BR)
AZEVEDO HATYLAS FELYPE ZANETI DE (BR)
JUNIOR MARCOS ANTONIO FERREIRA (BR)
GUIMARÃES CRISTIANO RUCH WERNECK (BR)
AZEVEDO HATYLAS FELYPE ZANETI DE (BR)
JUNIOR MARCOS ANTONIO FERREIRA (BR)
Application Number:
PCT/BR2018/050461
Publication Date:
June 20, 2019
Filing Date:
December 14, 2018
Export Citation:
Assignee:
ACHE LABORATORIOS FARMACEUTICOS SA (BR)
International Classes:
A61K31/517; C07D403/04
Other References:
See references of EP 3723759A4
Attorney, Agent or Firm:
EVANGELISTA, Katia J.F. (BR)
Download PDF: